AdvaMed moves for faster PMA (premarket approval) holds to meet MDUFMA goals
This article was originally published in Clinica
Executive Summary
Under pressure to meet performance goals stipulated under the medical device user fee law, FDA reviewers are increasingly opting to put difficult submissions on hold, a strategy that stops the review clock.